Shire PLC has announced that the FDA has accepted the Biologics License Application (BLA) for calaspargase pegol (Cal-PEG; SHP663). The...
Our current knowledge of the benefits and drawbacks of vitamin D supplements in pregnancy is insufficient to recommend their use, leading a team of researchers to analyse the current evidence with the aim of clarifying this contentious issue.
Objective: We evaluated the efficacy of topical fixed-dose combination calcipotriol 50 μg/g plus betamethasone dipropionate 0.5 mg/g cutaneous foam (Cal/BD foam) on itch, itch-related sleep loss and HRQoL vs. foam vehicle.
Prevention and treatment of vitamin D deficiency in adults and adolescents with an identified risk. As an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency.
The prevention and treatment of vitamin D deficiency in adults and adolescents with an identified risk. As an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency.